Cleveland HeartLab Adds New Patent for the Myeloperoxidase Test

Cleveland HeartLab adds a new patent to its portfolio of intellectual property rights for the Myeloperoxidase Test, a powerful biomarker for inflammation and its role in major cardiac events.